Search results
Showing 421 to 435 of 1373 results for social care
In development Reference number: GID-TA11733 Expected publication date: 26 August 2026
Obinutuzumab with immunosuppressive therapies for treating lupus nephritis [ID6420]
In development Reference number: GID-TA11478 Expected publication date: 11 March 2026
In development Reference number: GID-TA11508 Expected publication date: 29 July 2026
Acoramidis for treating transthyretin-related amyloidosis cardiomyopathy [ID6354]
In development Reference number: GID-TA11415 Expected publication date: 14 January 2026
In development Reference number: GID-TA11221 Expected publication date: TBC
In development Reference number: GID-TA11298 Expected publication date: 29 January 2026
Help make a difference on behalf of the people most affected by our recommendations on our voluntary and community sector forum.
Zilucoplan for treating antibody positive generalised myasthenia gravis [ID4008]
In development Reference number: GID-TA11096 Expected publication date: TBC
In development Reference number: GID-TA11545 Expected publication date: TBC
In development Reference number: GID-TA11484 Expected publication date: TBC
In development Reference number: GID-TA11405 Expected publication date: TBC
This guideline covers assessing and managing non-complex fractures that can be treated in the emergency department or orthopaedic clinic. It aims to improve practice so that people with fractures receive the care that they need without unnecessary tests and treatments.
This indicator covers the practice can produce a register of people with moderate to severe frailty. It measures outcomes that reflect the quality of care or processes linked by evidence to improved outcomes. This indicator was previously published as NM185
Adrenal insufficiency: identification and management (NG243)
This guideline covers identifying and managing adrenal insufficiency (hypoadrenalism) in babies, children, young people and adults. It aims to improve the treatment of primary, secondary and tertiary adrenal insufficiency, and the prevention and management of adrenal crisis.
This guideline covers assessing and managing faecal incontinence (any involuntary loss of faeces that is a social or hygienic problem) in people aged 18 and over. It aims to ensure that staff are aware that faecal incontinence is a sign or a symptom, not a diagnosis. It aims to improve the physical and mental health and quality of life of people with faecal incontinence.